Epicore Biosystems

Executive Summary

Epicore Biosystems, founded in 2015 and headquartered in Cambridge, MA, is a pioneering digital health company specializing in wearable microfluidic sweat sensors. Its platform enables continuous, non-invasive monitoring of key biomarkers—such as electrolytes, metabolites, and hydration markers—providing real-time insights into physiological status. Targeting industrial safety, sports and fitness, and clinical research markets, Epicore's technology addresses critical needs in heat stress prevention, athletic performance optimization, and remote patient monitoring. By leveraging advanced microfluidics and biomarker analytics, the company differentiates itself from conventional wearables through molecular-level sweat analysis, offering actionable data for hydration, nutrition, and stress management. With a strong intellectual property portfolio and collaborations with leading organizations like the U.S. Army and Gatorade Sports Science Institute, Epicore has demonstrated commercial traction in the industrial sector through its Connected Hydration solutions. The company is now scaling toward clinical applications, aiming to secure FDA clearances for medical-grade hydration and metabolic monitoring. As the wearable diagnostics market expands, Epicore is well-positioned to disrupt traditional point-of-care testing, though it faces competition from established players like Dexcom and Abbott in continuous monitoring. Key milestones include recent pilot programs with Fortune 500 manufacturers and pending regulatory submissions for sweat-based clinical biomarkers.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for sweat-based hydration monitor60% success
• Q3 2026Major contract with industrial safety company (e.g., construction or mining)70% success
• Q2 2026Series C funding round led by healthcare/strategic VC75% success